Patent Law Loophole Enables Access to Affordable Cystic Fibrosis Drug

A loophole in patent law is changing access to medical treatment. A generic version of a breakthrough cystic fibrosis drug is available. This version is manufactured in Bangladesh for much lower costs. The price is a fraction of what is charged in the United States. This development provides a lifeline to families who cannot afford care. Patients around the world may benefit from this lower-cost option. The drug is considered a miracle treatment for the condition. This shift highlights the impact of patent law on global health.